Activation of human telomerase reverse transcriptase through gene fusion in clear cell sarcoma of the kidney

Cancer Letters

Volumn 357, Issue 2, 2015, Pages 498-501

  Karlsson, Jenny ^a   Lilljebjörn, Henrik ^a   Holmquist Mengelbier, Linda ^a   Valind, Anders ^a   Rissler, Marianne ^a   Øra, Ingrid ^b   Fioretos, Thoas ^a   Gisselsson, David ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c Skåne Regional and University Laboratories   (Sweden)

Author keywords

Fusion transcript; IRX2; Pediatric kidney tumors; RNA sequencing; TERT

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR IRX2; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; IRX2 PROTEIN, HUMAN; ONCOPROTEIN; TELOMERASE; TERT PROTEIN, HUMAN;

ARTICLE; CHROMOSOME 5; CHROMOSOME REARRANGEMENT; CLEAR CELL SARCOMA OF THE KIDNEY; CLINICAL ARTICLE; EXON; GENE DELETION; GENE EXPRESSION; GENE FUSION; HEMIZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IRX2 TERT GENE; KIDNEY PARENCHYMA; KIDNEY SARCOMA; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; UNTRANSLATED REGION; UPREGULATION; ADULT; CLEAR CELL SARCOMA; EMBRYOLOGY; FETUS; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; KIDNEY TUMOR; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REGULATORY SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ADULT; BASE SEQUENCE; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MOLECULAR SEQUENCE DATA; ONCOGENE FUSION; ONCOGENE PROTEINS, FUSION; PROMOTER REGIONS, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOMA, CLEAR CELL; SEQUENCE ANALYSIS, RNA; TELOMERASE; TRANSCRIPTION FACTORS;

EID: 84920844167     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.11.057     Document Type: Article

References (21)

1. Seibel N.L., Li S., Breslow N.E., Beckwith J.B., Green D.M., Haase G.M., Ritchey M.L., Thomas P.R., Grundy P.E., Finklestein J.Z., Kim T., Shochat S.J., Kelalis P.P., D'Angio G.J. Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group. J. Clin. Oncol 2004, 22:468-473. [pii]. 10.1200/JCO.2004.06.058JCO.2004.06.058.
2. Argani P., Perlman E.J., Breslow N.E., Browning N.G., Green D.M., D'Angio G.J., Beckwith J.B. Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center. Am. J. Surg. Pathol 2000, 24:4-18.
3. Douglass E.C., Wilimas J.A., Green A.A., Look A.T. Abnormalities of chromosomes 1 and 11 in Wilms' tumor. Cancer Genet. Cytogenet 1985, 14:331-338.
4. Punnett H.H., Halligan G.E., Zaeri N., Karmazin N. Translocation 10;17 in clear cell sarcoma of the kidney. A first report. Cancer Genet. Cytogenet 1989, 41:123-128.
5. Sheng W.W., Soukup S., Bove K., Gotwals B., Lampkin B. Chromosome analysis of 31 Wilms' tumors. Cancer Res 1990, 50:2786-2793.
6. Kaneko Y., Homma C., Maseki N., Sakurai M., Hata J. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors. Cancer Res 1991, 51:5937-5942.
7. Rakheja D., Weinberg A.G., Tomlinson G.E., Partridge K., Schneider N.R. Translocation (10;17)(q22;p13): a recurring translocation in clear cell sarcoma of kidney. Cancer Genet. Cytogenet 2004, 154:175-179.
8. Brownlee N.A., Perkins L.A., Stewart W., Jackle B., Pettenati M.J., Koty P.P., Iskandar S.S., Garvin A.J. Recurring translocation (10;17) and deletion (14q) in clear cell sarcoma of the kidney. Arch. Pathol. Lab. Med 2007, 131:446-451.
9. O'Meara E., Stack D., Lee C.H., Garvin A.J., Morris T., Argani P., Han J.S., Karlsson J., Gisselson D., Leuschner I., Gessler M., Graf N., Fletcher J.A., O'Sullivan M.J. Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidney. J. Pathol 2012, 227:72-80. 10.1002/path.3985.
10. Shay J.W., Bacchetti S. A survey of telomerase activity in human cancer. Eur. J. Cancer 1997, 33:787-791. 10.1016/S0959-8049(97)00062-2.
11. Huang F.W., Hodis E., Xu M.J., Kryukov G.V., Chin L., Garraway L.A. Highly recurrent TERT promoter mutations in human melanoma. Science 2013, 339:957-959. 10.1126/science.1229259.
12. Horn S., Figl A., Rachakonda P.S., Fischer C., Sucker A., Gast A., Kadel S., Moll I., Nagore E., Hemminki K., Schadendorf D., Kumar R. TERT promoter mutations in familial and sporadic melanoma. Science 2013, 339:959-961. 10.1126/science.1230062.
13. Vinagre J., Almeida A., Populo H., Batista R., Lyra J., Pinto V., Coelho R., Celestino R., Prazeres H., Lima L., Melo M., da Rocha A.G., Preto A., Castro P., Castro L., Pardal F., Lopes J.M., Santos L.L., Reis R.M., Cameselle-Teijeiro J., Sobrinho-Simoes M., Lima J., Maximo V., Soares P. Frequency of TERT promoter mutations in human cancers. Nat. Commun 2013, 4:2185. 10.1038/ncomms3185.
14. Karlsson J., Holmquist Mengelbier L., Ciornei C.D., Naranjo A., O'Sullivan M.J., Gisselsson D. Clear cell sarcoma of the kidney demonstrates an embryonic signature indicative of a primitive nephrogenic origin. Genes Chromosomes Cancer 2014, 53:281-391. 10.1002/gcc.22149.
15. Leek J.T., Johnson W.E., Parker H.S., Jaffe A.E., Storey J.D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 2012, 28:882-883. 10.1093/bioinformatics/bts034.
16. Walther C., Tayebwa J., Lilljebjorn H., Magnusson L., Nilsson J., von Steyern F.V., Ora I., Domanski H.A., Fioretos T., Nord K.H., Fletcher C.D., Mertens F. A novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma. J. Pathol 2013, 232:534-540. 10.1002/path.4322.
17. Iyer M.K., Chinnaiyan A.M., Maher C.A. ChimeraScan: a tool for identifying chimeric transcription in sequencing data. Bioinformatics 2011, 27:2903-2904. 10.1093/bioinformatics/btr467.
18. Matsumoto K., Nishihara S., Kamimura M., Shiraishi T., Otoguro T., Uehara M., Maeda Y., Ogura K., Lumsden A., Ogura T. The prepattern transcription factor Irx2, a target of the FGF8/MAP kinase cascade, is involved in cerebellum formation. Nat. Neurosci 2004, 7:605-612. 10.1038/nn1249.
19. Choy S.W., Cheng C.W., Lee S.T., Li V.W., Hui M.N., Hui C.C., Liu D., Cheng S.H. A cascade of irx1a and irx2a controls shh expression during retinogenesis. Dev. Dyn 2010, 239:3204-3214. 10.1002/dvdy.22462.
20. Heliot C., Desgrange A., Buisson I., Prunskaite-Hyyrylainen R., Shan J., Vainio S., Umbhauer M., Cereghini S. HNF1B controls proximal-intermediate nephron segment identity in vertebrates by regulating Notch signalling components and Irx1/2. Development 2013, 140:873-885. 10.1242/dev.086538.
21. Daniel M., Peek G.W., Tollefsbol T.O. Regulation of the human catalytic subunit of telomerase (hTERT). Gene 2012, 498:135-146. 10.1016/j.gene.2012.01.095.